We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

DCL Medical Laboratories Sold to Laboratory Corporation of America

By LabMedica International staff writers
Posted on 28 Jul 2010
Thompson Street Capital Partners (St. Louis, MO, USA) have sold DCL Medical Laboratories, LLC (DCL) to Laboratory Corporation of America Holdings (LabCorp; Burlington, NC, USA), a U.S. provider of medical laboratory tests and services. Terms of the transaction were not disclosed.

DCL provides diagnostic and clinical trial testing services to physicians, hospitals, and pharmaceutical and medical device companies. The company provides anatomic pathology as well as clinical trial testing services and specializes in women's health.

LabCorp offers clinical assays ranging from routine blood analysis to HIV and genomic testing. DCL will join LabCorp's nationwide network of 38 primary testing locations and its industry-leading Centers of Excellence laboratories, including the Center for Esoteric Testing, Viro-Med, National Genetics Institute and US Labs.

In 2007, Thompson Street, together with Jack Bergstrom and Jay Tyler, acquired DCL from its founders. The goal of the transaction was to capitalize and expand the company's strong reputation in women's health. Thompson Street's managing partner, Jim Cooper, said, "We achieved this by growing our sales force and laboratory staff, increasing our participation in pharmaceutical and medical device clinical trials, and investing in our laboratory IT and test equipment infrastructure."

Related Links:
Thompson Street Capital Partners
Laboratory Corporation of America Holdings


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Online QC Software
Acusera 24•7
New
Rapid Sepsis Test
SeptiCyte RAPID
New
All-in-One Molecular System
AIO M160

Latest Industry News

Partnership Brings Single-Cell Analysis into Clinical Oncology Workflows
28 Jul 2010  |   Industry

Partnership Aims to Bring Risk-Guided CKD Care to Health Systems
28 Jul 2010  |   Industry

AI-Powered Multi-Functional Analyzer Wins German Innovation Award
28 Jul 2010  |   Industry



ADLM